CytomX Therapeutics Inc. (CTMX)
NASDAQ · Healthcare
CytomX Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 76.2M | 138.1M | 101.2M | 53.2M | 37.3M | 68.4M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -22.4M | 25.0M | -6.5M | -101.3M | -116.0M | -80.5M |
| EBITDA | -21.0M | 26.8M | -4.3M | -98.9M | -113.3M | -78.0M |
| Net Income | -17.4M | 31.9M | -569,000 | -99.3M | -115.9M | -64.8M |
| Per Share Data | ||||||
| EPS (diluted) | $-0.15 | $0.38 | $-0.01 | $-1.51 | $-1.30 | $-1.40 |
| Shares Outstanding (dil.) | 138M | 84M | 74M | 66M | 64M | 46M |
CytomX Therapeutics Inc. Income Statement — FAQ
CytomX Therapeutics Inc. (CTMX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTMX's income statement history?
The chart and table above show CytomX Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.